hexamethylene bisacetamide has been researched along with methylformamide in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hellinger, N; Scher, BM; Scher, W; Waxman, S | 1 |
Allalouf, D; Friedman, J; Levinsky, H; Seger, M | 1 |
Engers, R; Gabbert, HE; Gerharz, CD; Luley, C; Mayer, H; Ramp, U | 1 |
3 other study(ies) available for hexamethylene bisacetamide and methylformamide
Article | Year |
---|---|
Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide.
Topics: Acetamides; Animals; Cell Count; Cell Differentiation; Cell Division; Dexamethasone; Dimethyl Sulfoxide; DNA Repair; DNA, Neoplasm; Drug Synergism; Drug Therapy, Combination; Fluorouracil; Formamides; Leucovorin; Leukemia, Erythroblastic, Acute; Mice; Time Factors; Tumor Cells, Cultured | 1990 |
Modulation of carcinoembryonic antigen release by HT-29 colon carcinoma line in the presence of different agents.
Topics: Acetamides; Azacitidine; Butyrates; Butyric Acid; Carcinoembryonic Antigen; Cell Differentiation; Colonic Neoplasms; Drug Synergism; Formamides; Humans; Tetradecanoylphorbol Acetate; Tretinoin | 1987 |
Heterogeneous response to differentiation induction with different polar compounds in a clonal rat rhabdomyosarcoma cell line (BA-HAN-1C).
Topics: Acetamides; Animals; Antineoplastic Agents; Butyrates; Butyric Acid; Cell Differentiation; Cell Fusion; Cell Line; Clone Cells; Creatine Kinase; Dimethyl Sulfoxide; Formamides; Rats; Rhabdomyosarcoma; Tumor Cells, Cultured | 1989 |